The Monsenso digital health solution supports patients through their care journey and delivers clinical insights to the pharmaceutical industry.
The solution consists of a mobile app for individuals and carers and a web portal for clinicians or investigators. The patient app collects self-reported and sensor data from the app and wearables.
Real-world data can help clinicians personalise treatment and medication for better outcomes while providing pharma with real-world evidence base on safety and efficacy to support regulatory and payer requirements.
Our solution is used by patients with schizophrenia, bipolar disorder, depression, anxiety, borderline personality disorder, and PTSD.
Collect patient-reported outcome data from self-assessments, clinical questionnaires, and data from usage, voice analysis and sensors.
Improve medication adherence and treatment compliance through daily reminders coupled with maximum data security.
Engage patients throughout the patient journey and empower them to better manage their disease through better insights and tools.
Offer a digital health solution that enables clinicians to monitor patients remotely in an easy and cost-efficient way.
Our solution is highly scalable for global R&D projects. It can be used by small clinics, large hospitals and health systems in 10 languages. We can configure it to your specific requirements and deliver it as a white-label product.